Wolf Theiss

Wolf Theiss advises Takeda Pharmaceuticals again, this time with its acquisition of Plasmaspendedienst GmbH

Vienna, 3 April 2020 – Wolf Theiss has advised Takeda Pharmaceuticals with its acquisition of Plasmaspendedienst GmbH. The signing took place on 30 March.

Wolf Theiss advised Takeda Pharmaceuticals with the structuring of the transaction, legal due diligence, negotiation of the transaction and drafting of all transaction documents.

Under the lead Sarah Wared (M&A/Corporate), Kurt Retter, Dominik Engel (both Regulatory), Clemens Pretscher (M&A/Corporate), Vilma-Reeta Kivilahti (M&A/Finance), Walter Pöschl (Employment), Roland Marko, Paulina Pomorski (both IP/IT), Iris Riepan and Karl Binder (both Real Estate) worked on this transaction.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing better health to people worldwide. The passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.


For further information please contact

Barbara Fürchtegott
Public Relations & Communications Manager
T. +43 1 51510 3808
Schubertring 6
1010 Vienna

Find a Lawyer